Advertisement
Review article| Volume 7, ISSUE 3, P159-168, June 1994

Atopic dermatitis—immunological abnormality and its background

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The production of IgE is mainly regulated by cognate and/or non-cognate interaction between B cells and T cells. Two types of helper T cells are recognized in the murine system, Th1 and Th2, by the type of cytokine they produce. Several lines of evidence disclosed that unbalanced generation of Math Eq cells occurs in atopic disorders, such as atopic dermatitis, in which a high level of serum IgE is found in the majority of patients. Analysis of skin-derived immunocompetent cells, such as Langerhans cells and T cells, has provided us with a new understanding of the pathophysiology of atopic dermatitis. The recent progress in immunological aspects of atopic dermatitis is reviewed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hanifin JM
        Atopic dermatitis.
        J Am Acad Dermatol. 1982; 6: 1-13
        • Walker RB
        • Warin RP
        Incidence of eczema in early childhood.
        Br J Dermatol. 1956; 68: 182-183
        • Uehara M
        • Ofuji S
        Atopic dermatitis.
        in: Kukita A Sano H Seiji M Yamamura Y Gendai Hifukagaku Taikei 13. Nakayama-Shoten, Tokyo1980: 89-119 (Japanese)
        • Champion RH
        • Parish WE
        Atopic dermatitis.
        in: Champion RH Burton JL Ebling FJG Textbook of Dermatology. Blackwell Scientific Publications, Oxford1992: 589-610
        • Blumenthal MN
        • Yunis E
        • Mendell N
        • Elston RC
        Preventive allergy. Genetics of IgE-mediated diseases.
        J Allergy Clin Immunol. 1986; 78: 962-968
        • Miyazato M
        • Nakama T
        • Tsuda S
        Atopic dermatitis.
        in: Yoshida H Tsuda S Cutaneous infiltration of eosinophil and the related properties. Rinsyou-Iyaku-Kenkyu-Kyokai, Tokyo1991: 132-150 (Japanese)
        • Rubin LA
        • Kurman CC
        • Fritz ME
        • Biddison WE
        • Boutin B
        • Yarchoan R
        • Nelson DL
        Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
        J Immunol. 1985; 137: 3172-3177
        • Rubin LA
        • Jay G
        • Nelson DL
        The released interleukin 2 receptor binds interleukin 2 efficiently.
        J Immunol. 1986; 137: 3841-3844
        • Leiferman KM
        A current perspective on the role of eosinophils in dermatologic diseases.
        J Am Acad Dermatol. 1991; 24: 1101-1112
        • Colver GB
        • Symons JA
        Soluble interleukin 2 receptor in atopic eczema.
        Br Med J. 1989; 298: 1426-1428
        • Matsumoto T
        • Miike T
        • Yamaguchi K
        • Murakami M
        • Kawabe T
        • Yodoi J
        Serum levels of soluble IL-2 receptor, IL-4, and IgE-binding factors in childhood allergic diseases.
        Clin Exp Immunol. 1991; 85: 288-292
        • Kapp A
        • Czech W
        • Krutmann J
        • Schop E
        Eosinophil cationic protein in sera of patients with atopic dermatitis.
        J Am Acad Dermatol. 1991; 24: 555-558
        • Czech W
        • Krutmann J
        • Schopf E
        • Kapp A
        Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
        Br J Dermatol. 1992; 126: 351-355
        • Sillevis Smith JH
        • Bos JD
        • Hulsebosch HJ
        • Krieg SR
        In situ immunotyping of antigen presenting cells and T subsets in atopic dermatitis.
        Clin Exp Dermatol. 1986; 11: 159-168
        • Pene J
        • Rousset F
        • Briere F
        • Chrestien I
        • Paliard X
        • Bancherau J
        • Spits H
        • de Vries JE
        IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-γ.
        J Immunol. 1988; 141: 1218-1224
        • Yokota T
        • Arai N
        • de Vries JE
        • Spits H
        • Bancherau J
        • Zlotnik A
        • Rennick D
        • Howard M
        • Takebe Y
        • Miyatake S
        • Lee F
        • Arai K
        Molecular biology of interleukin 4 and interleukin 5 genes and biology of their products that stimulate B cells, T cells, and hemopoietic cells.
        Immunol Rev. 1988; 102: 137-187
        • Defrance T
        • Aubry JP
        • Rousset F
        • Vanbervliet B
        • Bonnefoy JY
        • Arai K
        • de Vries JE
        Human recombinant IL-4 induces Fc receptors (CD23) on normal B lymphocytes.
        J Exp Med. 1987; 16: 1459-1467
        • Nakamura K
        • Okubo Y
        • Minami M
        • Furue M
        • Ishibashi Y
        Phenotypic analysis of CD23+ peripheral blood mononuclear cells in atopic dermatitis.
        Br J Dermatol. 1991; 125: 543-547
        • Sakamoto T
        • Takigawa M
        • Tamamori T
        • Horiguchi D
        • Yamada M
        Fcϵ receptor Math Eq lymphocytes in atopic dermatitis: II. Infiltration of Fcϵ RII(+) T cells in the skin lesion.
        J Invest Dermatol. 1990; 95: 592-596
        • Yokota T
        • Arai N
        • Arai KI
        • Zlotnik A
        Interleukin-4.
        in: Sporn MB Roberts AB 6th Edn. Handbook of Experimental Pharmacology. Vol. 95/I. Springer-Verlag, Berlin1990: 577-607 (Peptide growth factors and their receptors I)
        • Habetswallner D
        • Pelosi E
        • Bulgarini D
        • Camagna A
        • Sammoggia P
        • Montesoro E
        • Gianella G
        • Lazzaro D
        • Isacchi G
        • Testa U
        • Peschle C
        Activation and proliferation of normal resting human T lymphocytes in serum-free culture. Role of IL-4 and IL-6.
        Immunology. 1988; 65: 357-364
        • Spiegelberg HL
        • O'Conner RD
        • Simon RA
        • Mathison DA
        Lymphocytes with immunoglobulin E Fc receptors in atopic patients with atopic dermatitis.
        J Clin Invest. 1979; 64: 714-720
        • Furue M
        • Ohtsuki M
        • Ogata F
        • Ishibashi Y
        Responsiveness to interleukin 4 and interleukin 2 of peripheral blood mononuclear cells in atopic dermatitis.
        J Invest Dermatol. 1991; 96: 468-472
        • Mihm Jr, MC
        • Soter NA
        • Dvorak HF
        The structure of normal skin and the morphology of atopic eczema.
        J Invest Dermatol. 1976; 67: 305-312
        • Bradding P
        • Feather IH
        • Howarth PH
        • Mueller R
        • Roberts JA
        • Britten K
        • Bews JPA
        • Hunt TC
        • Okayama Y
        • Heusser CH
        • Bullock GR
        • Church MK
        • Holgate ST
        Interleukin 4 is localized and released by human mast cells.
        J Exp Med. 1992; 176: 1381-1386
        • Moser R
        • Fehr J
        • Bruijnzeel PLB
        IL-4 controls the selective endothelium driven transmigration of eosinophils from allergic individuals.
        J Immunol. 1992; 149: 1432-1438
        • Parker CW
        • Kennedy S
        • Eisen AG
        Leukocyte and lymphocyte cyclic AMP responses in atopic eczema.
        J Invest Dermatol. 1968; 68: 203-232
        • Safko MJ
        • Chan SC
        • Cooper KD
        • Hanifin JM
        Heterologous desensitization of leukocytes: A possible mechanism of β-adrenergic blockade in atopic dermatitis.
        J Allergy Clin Immunol. 1981; 68: 218-225
        • Grewe SR
        • Chan SC
        • Hanifin JM
        Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: A possible mechanism for cyclic AMP agonist hyporesponsiveness.
        J Allergy Clin Immunol. 1982; 70: 452-457
        • Hanifin JM
        Phosphodiesterase and immune dysfunction in atopic dermatitis.
        J Dermatol Sci. 1990; 1: 1-6
        • Cooper KD
        • Kang K
        • Chan SC
        • Hanifin JM
        Phosphodiesterase inhibition by Ro 20-1724. Reduces hyper IgE synthesis by atopic dermatitis cells in vitro.
        J Invest Dermatol. 1985; 84: 477-482
        • Li SH
        • Chan SC
        • Toshitani A
        • Leung DYM
        • Hanifin JM
        Synergistic effects of interleukin 4 and interferon-γ on monocyte phosphodiesterase activity.
        J Invest Dermatol. 1992; 99: 65-70
        • Mosmann TR
        • Cherwinski H
        • Bond MW
        • Giedlin MA
        • Coffman RL
        Two types of helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
        J Immunol. 1986; 136: 2348-2357
        • Mosmann TR
        • Moore KW
        The role of IL-10 in crossregulation of Th1 and Th2 responses.
        Immunol Today. 1991; 12: A49-A53
        • Delespesse G
        • Sarfati M
        • Peleman R
        Influence of recombinant IL-4, IFN-α, and IFN-γ on the production of human IgE-binding factor (soluble CD23).
        J Immunol. 1989; 142: 134-138
        • Miyajima H
        • Hirano T
        • Hirose S
        • Karasuyama H
        • Okumura K
        • Ovary Z
        Suppression by IL-2 of IgE production by B cells stimulated by IL-4.
        J Immunol. 1991; 146: 457-462
        • Yamaguchi Y
        • Hayashi Y
        • Sugama Y
        • Miura Y
        • Kasahara T
        • Kitamura S
        • Torisu M
        • Mita S
        • Tominaga A
        • Takatsu K
        • Suda T
        Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival.
        J Exp Med. 1988; 167: 1737-1742
        • Kapsenberg ML
        • Wierenga EA
        • Bos JD
        • Jansen HM
        Functional subsets of allergen-reactive human CD4+ T cells.
        Immunol Today. 1991; 12: 392-395
        • Paliard X
        • Malefijt RDW
        • Yssel H
        • Blanchard D
        • Chrestien I
        • Abrams J
        • de Vries J
        • Spits H
        Simultaneous production of IL-2, IL-4, and IFN-γ by activated human CD4+ and CD8+ T cell clones.
        J Immunol. 1988; 141: 849-855
        • Rotteveel FTM
        • Kokkelink I
        • van Lien RAW
        • Kuenen B
        • Meager A
        • Miedema F
        • Lucas J
        Clonal analysis of functionally distinct human CD4+ T cell subsets.
        J Exp Med. 1988; 168: 1659-1673
        • Wierenga EA
        • Snoek M
        • Bos JD
        • Jansen HM
        • Kapsenberg ML
        Comparison of diversity and function of house dust mite-specific T lymphocytes clones from atopic and non-atopic donors.
        Eur J Immunol. 1990; 20: 1519-1526
        • Wierenga EA
        • Snoek M
        • de Groot C
        • Chrestien I
        • Bos JD
        • Jansen HM
        • Kapsenberg ML
        Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients.
        J Immunol. 1990; 144: 4651-4656
        • Del Prete G
        • Maggi E
        • Parronchi P
        • Chretien I
        • Tiri A
        • Macchia D
        • Ricci M
        • Banchereau J
        • de Vries J
        • Romagnani S
        IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants.
        J Immunol. 1988; 140: 4193-4198
        • Sinigaglia F
        • Scheidegger D
        • Garotta G
        • Scheper R
        • Pletscher M
        • Lauzavecchia A
        Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis.
        J Immunol. 1985; 135: 3929-3932
        • Parronchi P
        • Macchia D
        • Piccinni MP
        • Biswas P
        • Simonelli C
        • Maggi E
        • Ricci M
        • Ansari AA
        • Romagnani S
        Allergen- and bacterial antigen-specific T cell clones established from atopic donors show a different profile of cytokine production.
        in: 6th Edn. Proc Natl Acad Sci USA. 88. 1991: 4538-4542
        • Romagnani S
        • Del Prete G
        • Maggi E
        • Parronchi P
        • Tiri A
        • Macchia D
        • Giudizi MG
        • Almerigogna F
        • Ricci M
        Role of interleukins in induction and regulation of human IgE synthesis.
        Clin Immunol Immunopathol. 1989; 50: S13-S23
        • Jujo K
        • Renz H
        • Abe J
        • Gelfand EW
        • Leung YM
        Decreased interferon-γ and increased interleukin 4 production in atopic dermatitis promotes IgE synthesis.
        J Allergy Clin Immunol. 1992; 90: 323-331
        • Toshitani A
        • Ansel JC
        • Chan SC
        • Li SH
        • Hanifin JM
        Increased interleukin 6 production by T cells derived from patients with atopic dermatitis.
        J Invest Dermatol. 1993; 100: 299
        • Reinhold U
        • Pawelec G
        • Wehrman W
        • Herold M
        • Wernet P
        • Kreysel HW
        Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-γ and nepterin in patients with severe atopic dermatitis.
        Int Arch Allergy Appl Immunol. 1988; 87: 120-126
        • Kapp A
        • Kirnbauer R
        • Lugar TA
        • Schopf E
        Altered production of immuno-modulating cytokines in patients with atopic dermatitis.
        Acta Derm Venereol. 1989; 144 (Suppl): 97-99
        • Wehrman W
        • Reinhold U
        • Pawelec G
        • Wernet P
        • Kreysel HW
        In vitro generation of IFN-γ in relationship to in vivo concentration of IgE and IgG subclasses and Math Eq circulating lymphocytes in patients with severe atopic dermatitis (AD).
        Acta Derm Venereol. 1989; 144 (Suppl): 127-130
        • Reinhold U
        • Pawelec G
        • Wehrmann W
        • Kukel S
        • Oehr P
        • Kreysel HW
        Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis.
        Acta Derm Venereol. 1989; 69: 497-502
        • Takahashi T
        • Sasaki Y
        • Hama K
        • Furue M
        • Ishibashi Y
        Production of IL-4, IL-2, IFN-γ, and TNF-α by peripheral blood mononuclear cells of patients with atopic dermatitis.
        J Dermatol Sci. 1992; 3: 172-180
        • van der Heijden FL
        • Wierenga EA
        • Bos JD
        • Kapsenberg ML
        High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin.
        J Invest Dermatol. 1991; 97: 389-394
        • Sager N
        • Feldmann A
        • Schilling G
        • Kreitsch P
        • Neumann C
        House dust mite-specific T cells in the skin of subjects with atopic dermatitis. Frequency and lymphokine profile in the allergen patch test.
        J Allergy Clin Immunol. 1992; 89: 801-810
        • van Reijsen FC
        • Bruijnzeel-Koomen CAFM
        • Kalthoff FS
        • Maggi E
        • Romagnani S
        • Westland JKT
        • Mudde GC
        Skin-derived aeroallergen-specific T cell clones of Th2 phenotype in patients with atopic dermatitis.
        J Allergy Clin Immunol. 1992; 90: 184-192
        • Tanaka Y
        • Maeda K
        • Tanaka T
        • Yoshida H
        Patch test reaction of Dermatophagoides farinae in atopic dermatitis.
        Hifu. 1988; 30 (Japanese): 236-240
        • Hsieh CS
        • Macatonia SE
        • O'Garra A
        • Murphy KM
        Pathogen-induced Th1 phenotype development in CD4+ αβ-transgenic T cells is macrophage dependent.
        Int Immunol. 1993; 5: 371-382
        • Hsieh CS
        • Macatonia SE
        • Trip CS
        • Wolf SF
        • O'Garra A
        • Murphy KM
        Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.
        Science. 1993; 260: 547-549
        • Erard F
        • Wild MT
        • Garcia-Sanz JA
        • Gros GL
        Switch of CD8+ T cells to noncytolytic CD8-CD4-cells that make Th2 cytokines and help B cells.
        Science. 1993; 260: 1802-1805
        • Gajewski TF
        • Fitch FW
        Anti-proliferative effect of IFN-γ in immune regulation I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
        J Immunol. 1988; 140: 4245-4252
        • Cher D
        • Mosmann T
        Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones.
        J Immunol. 1987; 138: 3688-3694
        • Tite J
        • Powell M
        • Ruddle N
        Protein-antigen specific Ia-restricted cytolytic T cells: analysis of frequency, target cell susceptibility, and mechanism of cytolysis.
        J Immunol. 1985; 135: 25-33
        • Uehara M
        • Sawai T
        A longitudinal study of contact sensitivity in patients with atopic dermatitis. 1989; 125: 366-368
        • Clark RAF
        Cell-mediated and IgE-mediated immune responses in atopic dermatitis. 1989; 125: 413-416
        • Spitalny G
        • Havell E
        Monoclonal antibody to murine γ-interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.
        J Exp Med. 1984; 159: 1560-1565
        • Boguniewicz M
        • Jaffe HS
        • Izu A
        • Sullivan MJ
        • York D
        • Geha RS
        • Leung DYM
        Recombinant γ-interferon in treatment of patients with atopic dermatitis and elevated IgE levels.
        Am J Med. 1990; 88: 365-370
        • Hanifin JM
        • Schneider LC
        • Jaffe HS
        • Izu AE
        • Bucalo LR
        • Hirabavashi SE
        • Tofte SJ
        • Cantu-Gonzales G
        • Milgrom H
        • Boguniewicz M
        • Cooper KD
        Recombinant interferon γ-therapy for atopic dermatitis.
        J Am Acad Dermatol. 1993; 28: 189-197
        • Chien CH
        • Hsieh KH
        Interleukin 2 immunotherapy in children.
        Pediatrics. 1990; 86: 937-943
        • Fierlbeck G
        • Rassner G
        • Muller C
        Psoriasis induced at the injection site of recombinant interferon-γ.
        Arch Dermatol. 1990; 126: 351-355
        • Lee RE
        • Gaspari AA
        • Lotze MT
        • Chang AE
        • Rosenberg SA
        Interleukin 2 and psoriasis.
        Arch Dermatol. 1988; 124: 1811-1815
        • Uyemura K
        • Yamamura M
        • Fivenson DF
        • Modlin RL
        • Nickoloff BJ
        The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.
        J Invest Dermatol. 1993; 101: 701-705
        • Uno H
        • Hanifin JM
        Langerhans cells in acute and chronic epidermal lesions of atopic dermatitis observed by l-dopa histofluorescence, glycol methacrylate thin section, and electron microscopy.
        J Invest Dermatol. 1980; 75: 52-60
        • Rocha C
        • Maubeuge J
        • Sarfati M
        • et al.
        Characterization of cellular infiltrates in skin lesions of atopic eczema by means of monoclnal antibodies.
        Dermatologica. 1984; 169: 330-338
        • Cerio R
        • Spaull J
        • Oliver GF
        • Wilson Jones E
        A study of factor XIIIa and Mac 387 immunolabelling in normal and pathologic skin.
        Am J Dermatopathol. 1990; 12: 221-233
        • Bruijnzeel-Koomen CAFM
        • van Wichen DF
        • Toonstra J
        • Berrens L
        • Bruijnzeel PLB
        The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis.
        Arch Dermatol Res. 1986; 278: 199-205
        • Mudde GC
        • Vanreijsen FG
        • Boland CJ
        • de Cast GC
        • Bruijnzeel PLB
        • Bruijnzeel-Koomen CAFM
        Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE.
        Immunology. 1990; 69: 335-341
        • Bieber T
        • Braun-Falco O
        IgE-bearing Langerhans cells are not specific to atopic eczema but are found in inflammatory skin diseases.
        J Am Acad Dermatol. 1991; 24: 658-659
        • Bieber T
        • Rieger A
        • Neuchrist C
        • Prinz JC
        • Rieber EP
        • Boltz-Nitulescu G
        • Scheiner C
        • Kraft D
        • Ring J
        • Stingl G
        Induction of Math Eq on human epidermal Langerhans cells by human recombinant interleukin 4 and γ-interferon.
        J Exp Med. 1989; 170: 309-314
        • Wang B
        • Rieger A
        • Kilgus O
        • Ochiai K
        • Maurer D
        • Fodinger D
        • Kinet JP
        • Stingl G
        Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcϵRI.
        J Exp Med. 1992; 175: 1353-1365
        • Taylor RS
        • Baadsgaard O
        • Hammerberg C
        • Cooper KD
        Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
        J Immunol. 1991; 147: 3794-3802
        • Tiegs SL
        • Evavold BD
        • Yokoyama A
        • Stec S
        • Quintans J
        • Rowley D
        Delayed antigen presentation by epidermal Langerhans cells to cloned Th1 and Th2 cells.
        J Invest Dermatol. 1990; 95: 446-449
        • Simon JC
        • Krutmann J
        • Elmets CA
        • Bergstresser PR
        • Cruz Jr, PD
        Ultraviolet B-irradiated antigen presenting cells display altered accessory signaling for T cell activation: Relevance to immune responses initiated in skin.
        J Invest Dermatol. 1992; 98: 66S-69S
        • Muller KM
        • Jaunin F
        • Masouye I
        • Saurat JH
        • Hauser C
        Th2 cells mediate IL-4-dependent local tissue inflammation.
        J Immunol. 1993; 150: 5576-5584